#METABOLOMICS WORKBENCH SIMR_Core_Facility_20231129_202258 DATATRACK_ID:4483 STUDY_ID:ST003029 ANALYSIS_ID:AN004966 PROJECT_ID:PR001882
VERSION             	1
CREATED_ON             	December 27, 2023, 1:41 am
#PROJECT
PR:PROJECT_TITLE                 	Estrogen-mediated inhibition of purine metabolism and cell cycle arrest as a
PR:PROJECT_TITLE                 	novel therapeutic approach in colorectal cancer cells
PR:PROJECT_SUMMARY               	Purine metabolism is upregulated in various cancers including colorectal cancer
PR:PROJECT_SUMMARY               	(CRC). While previous research has elucidated the role of Estrogen (E2) in
PR:PROJECT_SUMMARY               	metabolism remodeling and ATP production, its effects on purine metabolism
PR:PROJECT_SUMMARY               	remained unexplored. This study investigates the impact of E2 signalling on
PR:PROJECT_SUMMARY               	purine metabolism in CRC cells. We demonstrate, for the first time, a protective
PR:PROJECT_SUMMARY               	effect of E2 on CRC cells by targeting the purine synthesis pathway through its
PR:PROJECT_SUMMARY               	receptor estrogen receptor α (ERα). A full metabolomic profiling, next
PR:PROJECT_SUMMARY               	generation sequencing (NGS) and integrated OMICS were conducted for HCT-116
PR:PROJECT_SUMMARY               	cells treated with E2 with and without silencing ERα. Our results revealed an
PR:PROJECT_SUMMARY               	enrichment of the purine metabolic pathway, with 27 genes in the de novo purine
PR:PROJECT_SUMMARY               	synthesis pathway downregulated in E2-treated CRC cells. Besides, E2-induced DNA
PR:PROJECT_SUMMARY               	damage, cell cycle arrest, and apoptosis are ERα-dependent. Our findings
PR:PROJECT_SUMMARY               	suggest potential therapeutic avenues for CRC treatment through antimetabolites
PR:PROJECT_SUMMARY               	targeting purine synthesis, as E2 treatment reduces the expression of relevant
PR:PROJECT_SUMMARY               	metabolites.
PR:INSTITUTE                     	Sharjah Institute for Medical Research
PR:LAST_NAME                     	Facility
PR:FIRST_NAME                    	Core
PR:ADDRESS                       	M32, SIMR, College of Pharmacy, Health Sciences, University of Sharjah
PR:EMAIL                         	tims-tof@sharjah.ac.ae
PR:PHONE                         	065057656
#STUDY
ST:STUDY_TITLE                   	Estrogen-mediated inhibition of purine metabolism and cell cycle arrest as a
ST:STUDY_TITLE                   	novel therapeutic approach in colorectal cancer cells
ST:STUDY_SUMMARY                 	Purine metabolism is upregulated in various cancers including colorectal cancer
ST:STUDY_SUMMARY                 	(CRC). While previous research has elucidated the role of Estrogen (E2) in
ST:STUDY_SUMMARY                 	metabolism remodeling and ATP production, its effects on purine metabolism
ST:STUDY_SUMMARY                 	remained unexplored. This study investigates the impact of E2 signalling on
ST:STUDY_SUMMARY                 	purine metabolism in CRC cells. We demonstrate, for the first time, a protective
ST:STUDY_SUMMARY                 	effect of E2 on CRC cells by targeting the purine synthesis pathway through its
ST:STUDY_SUMMARY                 	receptor estrogen receptor α (ERα). A full metabolomic profiling, next
ST:STUDY_SUMMARY                 	generation sequencing (NGS) and integrated OMICS were conducted for HCT-116
ST:STUDY_SUMMARY                 	cells treated with E2 with and without silencing ERα. Our results revealed an
ST:STUDY_SUMMARY                 	enrichment of the purine metabolic pathway, with 27 genes in the de novo purine
ST:STUDY_SUMMARY                 	synthesis pathway downregulated in E2-treated CRC cells. Besides, E2-induced DNA
ST:STUDY_SUMMARY                 	damage, cell cycle arrest, and apoptosis are ERα-dependent. Our findings
ST:STUDY_SUMMARY                 	suggest potential therapeutic avenues for CRC treatment through antimetabolites
ST:STUDY_SUMMARY                 	targeting purine synthesis, as E2 treatment reduces the expression of relevant
ST:STUDY_SUMMARY                 	metabolites.
ST:INSTITUTE                     	Sharjah Institute for Medical Research
ST:LAST_NAME                     	Facility
ST:FIRST_NAME                    	Core
ST:ADDRESS                       	M32, SIMR, College of Pharmacy, Health Sciences, University of Sharjah, Sharjah,
ST:ADDRESS                       	UAE, Sharjah, 000, United Arab Emirates
ST:EMAIL                         	tims-tof@sharjah.ac.ae
ST:PHONE                         	+971 6 5057656
#SUBJECT
SU:SUBJECT_TYPE                  	Cultured cells
SU:SUBJECT_SPECIES               	Colorectal cancer cells
#SUBJECT_SAMPLE_FACTORS:         	SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Raw file names and additional sample data
SUBJECT_SAMPLE_FACTORS           	-	control_1-01-8852	Treatment:Control	RAW_FILE_NAME=control_1-01-8852.d
SUBJECT_SAMPLE_FACTORS           	-	control_1-02-8853	Treatment:Control	RAW_FILE_NAME=control_1-02-8853.d
SUBJECT_SAMPLE_FACTORS           	-	control_2-01-8854	Treatment:Control	RAW_FILE_NAME=control_2-01-8854.d
SUBJECT_SAMPLE_FACTORS           	-	control_2-02-8855	Treatment:Control	RAW_FILE_NAME=control_2-02-8855.d
SUBJECT_SAMPLE_FACTORS           	-	control_3-01-8856	Treatment:Control	RAW_FILE_NAME=control_3-01-8856.d
SUBJECT_SAMPLE_FACTORS           	-	control_3-02-8857	Treatment:Control	RAW_FILE_NAME=control_3-02-8857.d
SUBJECT_SAMPLE_FACTORS           	-	E2_1-01-8860	Treatment:17-β-estradiol	RAW_FILE_NAME=E2_1-01-8860.d
SUBJECT_SAMPLE_FACTORS           	-	E2_1-02-8861	Treatment:17-β-estradiol	RAW_FILE_NAME=E2_1-02-8861.d
SUBJECT_SAMPLE_FACTORS           	-	E2_2-01-8862	Treatment:17-β-estradiol	RAW_FILE_NAME=E2_2-01-8862.d
SUBJECT_SAMPLE_FACTORS           	-	E2_2-02-8863	Treatment:17-β-estradiol	RAW_FILE_NAME=E2_2-02-8863.d
SUBJECT_SAMPLE_FACTORS           	-	E2_3-01-8864	Treatment:17-β-estradiol	RAW_FILE_NAME=E2_3-01-8864.d
SUBJECT_SAMPLE_FACTORS           	-	E2_3-02-8865	Treatment:17-β-estradiol	RAW_FILE_NAME=E2_3-02-8865.d
#COLLECTION
CO:COLLECTION_SUMMARY            	HCT-116 cells were cultured using a complete RPMI-1640 medium (Sigma-Aldrich,
CO:COLLECTION_SUMMARY            	St. Louis, MO, USA), supplemented with 2 mM l-glutamine, 1% non-essential amino
CO:COLLECTION_SUMMARY            	acids, 100 U/mL penicillin, 100 µg/mL streptomycin, and 10% fetal bovine serum.
CO:COLLECTION_SUMMARY            	Depending on each experimental run, HCT-116 cells were seeded and incubated at
CO:COLLECTION_SUMMARY            	37°C in a 5% CO2 environment for 24 hours
CO:SAMPLE_TYPE                   	Colerectal cancer cells
#TREATMENT
TR:TREATMENT_SUMMARY             	20 nM 17-β-estradiol (E2), diluted in 70% ethanol, (Sigma-Aldrich, St. Louis,
TR:TREATMENT_SUMMARY             	MO, USA), was introduced to the cells for 48 hours. Cells designated as control
TR:TREATMENT_SUMMARY             	received the same volume of 70% ethanol, serving as the vehicle.
#SAMPLEPREP
SP:SAMPLEPREP_SUMMARY            	To assess the intracellular metabolites, whole metabolites levels were measured
SP:SAMPLEPREP_SUMMARY            	after proper treatment. In brief, 1.0 × 106 of HCT-116 cells were collected and
SP:SAMPLEPREP_SUMMARY            	cell extracts were washed twice with 5% of mannitol. The pellet was lysed using
SP:SAMPLEPREP_SUMMARY            	400 uL of protease inhibitor dissolved in lysis buffer, allowing it to sit for
SP:SAMPLEPREP_SUMMARY            	10 minutes at room temperature. Subsequently, all samples underwent 30 seconds
SP:SAMPLEPREP_SUMMARY            	of vortexing and were sonicated using either the COPLEY sonicator or QSONICA
SP:SAMPLEPREP_SUMMARY            	SONICATOR (Qsonica, Newtown, CT, USA) at 30% AMP for 30 seconds until the
SP:SAMPLEPREP_SUMMARY            	pellets dissolved. The resulting solution was transferred to new Eppendorf tubes
SP:SAMPLEPREP_SUMMARY            	and centrifuged at 14000 rpm for 5 minutes. After centrifugation, the
SP:SAMPLEPREP_SUMMARY            	supernatant layer was carefully moved to another Eppendorf tube, to which 400 uL
SP:SAMPLEPREP_SUMMARY            	of methanol and 300 uL of chloroform were added. Each mixture was vortexed for
SP:SAMPLEPREP_SUMMARY            	30 seconds and then centrifuged at 14000 rpm for 5 minutes. The upper layer was
SP:SAMPLEPREP_SUMMARY            	transferred and stored in a glass vial. For washing, 300 uL of methanol was
SP:SAMPLEPREP_SUMMARY            	added to the white disk and lower layer, vortexed until the white disk broke and
SP:SAMPLEPREP_SUMMARY            	settled at the bottom of the Eppendorf. Subsequently, samples were centrifuged
SP:SAMPLEPREP_SUMMARY            	at 14000 rpm for 3 minutes, and the supernatant was transferred into the same
SP:SAMPLEPREP_SUMMARY            	glass vial. To dry the solvent, the samples were processed in the EZ-2 Plus
SP:SAMPLEPREP_SUMMARY            	(GeneVac, Ipswich, UK) at 37 ± 1 °C. The dried samples were resuspended with
SP:SAMPLEPREP_SUMMARY            	200 µL (0.1% formic acid in deionized water) and vortexed for 2 minutes for
SP:SAMPLEPREP_SUMMARY            	thorough mixing. Finally, the samples were filtered using a hydrophilic nylon
SP:SAMPLEPREP_SUMMARY            	syringe filter with a 0.45 µm pore size and returned to the glass insert within
SP:SAMPLEPREP_SUMMARY            	LC glass vials for analysis by Q-TOF MS. A quality control (QC) sample was
SP:SAMPLEPREP_SUMMARY            	prepared by pooling the same volume (10 uL) from each sample, and all samples
SP:SAMPLEPREP_SUMMARY            	were placed in the autosampler at a temperature set at 4℃.
#CHROMATOGRAPHY
CH:CHROMATOGRAPHY_SUMMARY        	An ultra-high-performance liquid chromatography system; Elute UHPLC (Bruker
CH:CHROMATOGRAPHY_SUMMARY        	Daltonik GmbH, Bremen, Germany) . 10 µL aliquot of the sample was injected and
CH:CHROMATOGRAPHY_SUMMARY        	the separation was performed on a Hamilton® Intensity Solo C18 column (2.1 ×
CH:CHROMATOGRAPHY_SUMMARY        	100 mm, 1.8 µm) (Bruker Daltonik) in a column oven temperature set at 35 ◦C ,
CH:CHROMATOGRAPHY_SUMMARY        	using solvent A (0.1% formic acid in deionized Water) and solvent B (0.1% formic
CH:CHROMATOGRAPHY_SUMMARY        	acid in acetonitrile) with the following gradient elution mode: 0 to 2 min, 1%
CH:CHROMATOGRAPHY_SUMMARY        	B; 2 to 17 min, 1–99% B; 17 to 20 min, 99% B; 20 to 20.1 min, 99–1% B; 20.1
CH:CHROMATOGRAPHY_SUMMARY        	to 30 min, 1% B. The flow rate was 0.25 mL/min from 0 to 20 min, 0.35 mL/min
CH:CHROMATOGRAPHY_SUMMARY        	from 20 min to 28.3 min, and 0.25 mL/min from 28.3 to 30 min.
CH:CHROMATOGRAPHY_TYPE           	Reversed phase
CH:INSTRUMENT_NAME               	Bruker Elute
CH:COLUMN_NAME                   	Hamilton® Intensity Solo 2 C18 column (2.1 × 100 mm, 1.8 µm)
CH:SOLVENT_A                     	Water (0.1% Formic Acid)
CH:SOLVENT_B                     	ACN (0.1% Formic Acid)
CH:FLOW_GRADIENT                 	gradient elution mode: 0 to 2 min, 1% B; 2 to 17 min, 1–99% B; 17 to 20 min,
CH:FLOW_GRADIENT                 	99% B; 20 to 20.1 min, 99–1% B; 20.1 to 30 min, 1% B.
CH:FLOW_RATE                     	The flow rate was 0.25 mL/min from 0 to 20 min, 0.35 mL/min from 20 min to 28.3
CH:FLOW_RATE                     	min, and 0.25 mL/min from 28.3 to 30 min.
CH:COLUMN_TEMPERATURE            	35 ◦C
#ANALYSIS
AN:ANALYSIS_TYPE                 	MS
#MS
MS:INSTRUMENT_NAME               	Bruker timsTOF
MS:INSTRUMENT_TYPE               	QTOF
MS:MS_TYPE                       	ESI
MS:ION_MODE                      	POSITIVE
MS:MS_COMMENTS                   	The ESI source condition for every injection was as follows: The drying gas flow
MS:MS_COMMENTS                   	rate was 10.0 L/min at a temp of 220 ◦C; the capillary voltage was set at 4500
MS:MS_COMMENTS                   	V; the End Plate offset was set at 500 V; the nebulizer pressure of 2.2 bar. The
MS:MS_COMMENTS                   	acquisition involved two segments; auto MS scan, which ranged from 0 to 0.3 min
MS:MS_COMMENTS                   	for the calibrant sodium formate, and auto MS/MS scan with CID acquisition,
MS:MS_COMMENTS                   	which included fragmentation and ranged from 0.3 to 30 min. The acquisition in
MS:MS_COMMENTS                   	both segments was performed using the positive mode at 12 Hz. The automatic
MS:MS_COMMENTS                   	in-run mass scan range was from 50 to 1300 m/z, the width of the precursor ion
MS:MS_COMMENTS                   	was ±0.5, the cycle time was 0.5 sec, and the threshold was 400 cts. Active
MS:MS_COMMENTS                   	exclusion was excluded after 3 spectra and released after 0.2 min. For MS2
MS:MS_COMMENTS                   	acquisition the data dependent acquisition (DDA) was used, and the collision
MS:MS_COMMENTS                   	energy stepping fluctuated between 100 and 250% set at 20 eV. M/Z measurements
MS:MS_COMMENTS                   	were externally calibrated using 10 mM of sodium formate before sample analysis.
MS:MS_COMMENTS                   	In addition, sodium formate solution was injected at the beginning of each
MS:MS_COMMENTS                   	sample run and used for internal calibration during data processing
MS:MS_COMMENTS                   	TRX-2101/RT-28-calibrants for Bruker T-ReX LC-QTOF (Nova Medical Testing Inc.)
MS:MS_COMMENTS                   	was injected before sample analysis to check and test the performance of the
MS:MS_COMMENTS                   	column, reversed-phase liquid chromatography (RPLC) separation, multipoint
MS:MS_COMMENTS                   	retention time calibration, and the mass spectrometer. Also, TRX-3112-R/MS
MS:MS_COMMENTS                   	Certified Human serum for Bruker T-ReX LC-QTOF solution (Nova Medical Testing
MS:MS_COMMENTS                   	Inc.) was prepared from pooled human blood and injected before sample analysis
MS:MS_COMMENTS                   	to check the performance of the LC-MS instruments.
#MS_METABOLITE_DATA
MS_METABOLITE_DATA:UNITS	AU
MS_METABOLITE_DATA_START
Samples	control_1-01-8852	control_1-02-8853	control_2-01-8854	control_2-02-8855	control_3-01-8856	control_3-02-8857	E2_1-01-8860	E2_1-02-8861	E2_2-01-8862	E2_2-02-8863	E2_3-01-8864	E2_3-02-8865
Factors	Treatment:Control	Treatment:Control	Treatment:Control	Treatment:Control	Treatment:Control	Treatment:Control	Treatment:17-β-estradiol	Treatment:17-β-estradiol	Treatment:17-β-estradiol	Treatment:17-β-estradiol	Treatment:17-β-estradiol	Treatment:17-β-estradiol
1-Methyladenosine	1792	1340	1422	878	1192	1092	692	706	1144	748	470	400
17-Hydroxyprogesterone	4704	5764	3402	4312	8938	7568	6814	7974	3112	5258	2214	10110
2'-Deoxyguanosine 5'-monophosphate	2544	1978	3066	2708	3664	3624	2416	2524	3494	3616	3064	3608
2,4-Diaminobutyric acid	29300	26700	51202	56194	15308	13204	14296	12258	33566	28536	53766	50140
2-Ethyl-2-hydroxybutyric acid	54634	51002	48736	52232	51790	53312	37078	35918	47728	45742	30236	28900
2-Hydroxyadenine	42140	47800	58240	55158	44602	46120	36540	37378	15726	14138	38084	38004
2-Phenylaminoadenosine	114630	98216	135362	95490	88502	80058	45012	48366	92588	73972	47710	45360
2-Phenylbutyric acid	60676	60586	60924	58712	61314	57832	56260	57248	59266	57020	58922	51314
2-Pyrrolidinone	10586	11184	12840	9080	9040	11232	9176	8776	11254	10832	10546	10018
3,4-Dihydroxyphenylglycol	1348	1058	1250	906	994	1158	938	974	1142	992	668	796
3-Hydroxy-4-methoxycinnamic aicd	5870	6084	6202	4810	4808	5686	4620	4608	4706	4292	4914	5020
3-Methylindole	4200	3758	4666	4196	3490	3228	4422	4334	3878	3278	4066	3558
3a,6b,7b-Trihydroxy-5b-cholanoic acid	253438	247570	256244	237640	256832	236168	289790	287014	270006	280844	265954	276420
5'-Methylthioadenosine	98110	95468	109700	107952	101042	104790	110326	104144	111126	109818	105850	88100
5-Aminopentanoic acid	3740	2912	4098	3368	2150	2438	4182	3296	3308	3966	3238	2622
5-Methoxysalicylic acid	27922	28946	36114	24706	28838	26732	20360	23222	33984	25878	17528	15562
5-Methoxytryptophol	3156	2986	2924	2402	2332	2612	718	724	1692	1582	844	858
7,8-Dihydrobiopterin	650	838	1442	1516	1362	2074	1050	1360	1484	2038	1302	1028
Acetoin	349224	308798	407986	324356	219948	207578	179298	175446	384658	309040	412804	202184
Adenine	93420	96096	91812	97126	78258	87466	74956	70612	100330	103244	90572	85946
Adenosine	188028	180662	185630	197824	179958	159476	153044	154300	201464	215530	181878	164412
Adenosine 3',5'-diphosphate	38094	37354	36854	35518	37976	37322	19784	20764	26604	26816	33412	34132
Adenosine monophosphate	3450	4838	3754	9678	9008	9702	11892	10530	8630	6904	6116	9790
Adenosine triphosphate	3366	2498	1010	3220	3012	3564	1186	1362	1864	1556	3602	3052
Allocholic acid	7008	6616	7112	7276	4792	4234	3532	3942	6262	6726	6532	6022
Androstenedione	7132	8200	6310	6690	7872	6312	7150	6592	8230	10526	11702	10024
Aspartame	3856	3220	3464	3960	4330	2680	3678	3462	3586	3658	3636	3346
Aspirin	2870	2854	3328	3148	2810	2732	3558	3394	2954	2884	2896	2734
Atenolol	3046	1892	2679	2626	2590	2380	636	590	1876	1274	1624	1520
Benzoic acid	3970	3884	3884	3982	3888	3858	4572	4758	4138	3906	4714	4562
Carnosine	26988	18910	29906	23838	21584	24642	23952	23406	23352	23896	25430	24190
Cinnamaldehyde	18038	18046	18966	17188	16832	16990	15154	15457	19984	17610	18676	19050
Clotrimazole	1416	1766	1654	1864	2172	2342	1992	2134	1704	1842	2546	1942
Coumarin	2630	2362	2692	2992	2540	2662	2686	2838	2690	2590	2592	2576
Cyclic AMP	1634	1690	1532	1766	1924	2054	1014	1152	1538	1210	1320	1620
Cytosine	1482	1276	1772	1766	1442	1122	2432	2546	2148	2128	2292	2338
D-Glucurono-6,3-lactone	7800	8242	7656	8606	9220	8460	6662	7798	8252	8398	8960	8286
Diacetyl	11878	12306	12430	10512	11440	10370	6708	9846	9318	9406	12318	10088
Diethanolamine	1018	1272	1206	880	1052	1550	450	548	306	312	1484	576
Dopamine	1714	1688	1720	1202	1762	1818	1566	1564	2050	1854	1574	1834
Elaidic acid	8330	8244	8202	6928	7766	5534	4936	5340	4988	5108	6036	5390
Epinephrine	4150	5618	5286	5022	5578	6394	4468	4398	7258	6298	6480	5782
Folic acid	2684	2018	3426	2794	2242	2880	4768	4284	4520	4316	3260	2734
Galactitol	14818	15792	14156	15634	15836	14292	14580	16206	15284	15306	14160	14092
Gamma-Caprolactone	3052	3012	2992	3052	2354	2468	2316	2710	2370	2440	3044	3068
Gluconolactone	7078	12084	8054	20866	33682	32212	19298	18974	40010	40534	24746	21728
Glucosamine	610	598	384	542	588	576	424	416	0	0	0	0
Glutathione	32882	50074	39990	98554	134094	128832	82958	87824	179124	154850	101490	90748
Glycerophosphocholine	2988	2672	2950	2618	3720	3886	3614	4026	2928	2852	3662	3882
Guanidinosuccinic acid	39204	40296	33460	40236	24162	20754	35630	36572	54766	48546	47760	31308
Guanosine	25076	23742	22912	25756	22922	25762	20158	20662	7042	7590	19076	18364
Guanosine 5'-diphosphate	3502	3556	2022	2516	3254	3576	2784	2816	3410	2384	3124	2804
Guanosine monophosphate	2030	2010	1682	1800	2294	1970	2146	1702	1994	1980	1932	2070
Hydroxyisocaproic acid	0	0	249253	244366	205820	189848	177610	183584	275296	280802	142604	139808
Hyodeoxycholic acid	32806	34686	22988	30718	16218	14542	55682	57964	16766	22904	17614	26844
Hypoxanthine	208428	197474	228268	249928	225990	229914	179562	191810	213342	220792	207594	203876
Indole	24550	24312	29638	25746	22148	22128	27276	27214	27814	25358	25752	20150
Indoleacrylic acid	130402	134012	163218	147038	115838	116350	156778	157150	143190	142482	140828	112546
Inosine	106072	107714	94774	98158	93046	96910	73038	78902	82566	82750	80720	84382
Isobutyric acid	404650	340276	530622	390930	256926	241186	225082	222974	419316	348942	525200	217580
Isovalerylcarnitine	379606	405340	422288	392800	384286	370162	314368	288336	316798	334004	320290	311408
L-Acetylcarnitine	43388	43716	46470	39346	40034	39944	39906	44844	46804	45102	51992	45880
L-Fucose	2242	2676	2602	2600	2376	2104	2200	2240	2332	2102	2646	2452
L-Glutamic acid	712	1048	1090	1198	1202	1280	1330	878	1026	1226	1332	936
L-Leucine	16536	15764	16124	18026	14784	16558	18214	18516	16262	16226	15146	17416
L-Methionine	7530	8546	6008	7870	7798	7582	9794	9920	7622	7740	8432	10168
L-Norleucine	9318	9144	8078	7716	8016	8270	8784	8626	9824	9702	11448	11492
L-Phenylalanine	29842	32546	31642	28850	29146	27724	34424	35508	28176	31606	30406	28330
L-Proline	1370	1196	1616	1384	2008	1546	1464	1874	1308	2320	1746	1530
L-Thyronine	2090	2242	1946	2150	2514	2322	2174	2154	2116	2250	2254	2326
L-Tryptophan	34588	30358	39106	34084	28780	29116	37524	37752	34336	34212	33574	29124
L-Tyrosine	3906	3248	5148	5676	3284	3344	8502	9270	2620	2582	4620	4598
Leucinic acid	49150	51026	52012	46422	40700	38496	34840	34000	43796	44426	47380	48356
m-Coumaric acid	8498	9426	9438	9798	10424	9542	12678	10704	9896	9686	9244	8866
Maltitol	51980	51538	50142	49346	52760	50128	49178	51456	42808	51288	53814	44736
Mannitol	31282	32136	37278	35278	33060	32828	32118	33584	29096	30412	34110	28494
Methyl propenyl ketone	2198	1348	1914	1518	1816	1918	1382	1376	1602	1388	804	788
Methylhippuric acid	10346	8960	11408	9006	9244	8366	9436	9216	9998	9852	9046	8326
Metoprolol	10108	9642	11588	8048	5440	5228	7564	6978	9978	8684	12144	4282
Mevalonic acid	12134	12936	8652	12798	13394	13932	9600	10614	8826	12706	15198	8518
N,N-Dimethylformamide	1784	1778	1256	1438	1860	1662	1320	1480	1314	1476	1336	1640
N-Acetyl-L-alanine	18794	17904	18478	18492	19842	20254	18404	18370	16040	18316	19192	18888
N-Acetylglutamic acid	1342	1536	1898	1618	2032	1992	1246	1338	2434	1602	1844	1968
N-Acetylserotonin	9384	7554	14038	14674	7716	7318	6500	7008	9586	8794	8242	7996
N-Methyl-D-aspartic acid	3606	3110	3494	2706	2948	3366	2944	3050	4058	3682	4616	4010
Niacinamide	22670	28494	17816	16632	29940	32402	39296	37398	29988	28680	38984	38208
Nicotinic acid	34638	35708	36758	38134	43094	38720	37860	39480	29344	29164	36204	37874
Nutriacholic acid	218848	225166	142766	218216	216752	228326	177572	181198	130424	145980	193664	202292
o-Tyrosine	2696	2970	3736	4318	2476	1898	6838	7218	2334	2050	3430	3664
Pantothenic acid	50684	54620	48638	47322	52928	57644	50266	52986	60034	62082	60322	53504
Phenol	1124	1496	1380	1464	1414	1242	1594	1358	1582	1700	1492	1122
Phenylacetaldehyde	24748	22648	25432	22262	25380	23866	24410	25158	22346	20974	20490	22370
Phosphocreatine	77598	68144	122154	89846	59326	62064	62470	62458	96974	100496	137854	54804
Pregnenolone sulfate	58306	57046	55396	57772	58246	54498	44656	49996	50260	52320	51694	42458
Propionic acid	21260	16610	31718	22880	20650	22466	17378	16952	26378	20646	35860	24330
Propranolol	664	860	1212	998	1370	1052	1612	1326	642	1094	1060	788
Pyridine	5052	6520	4536	5480	5168	6522	8142	5434	7670	6258	5498	5948
Pyridoxine	2370	3306	2706	2634	2374	2482	4212	4930	3320	3574	2648	3430
Pyrrolidonecarboxylic acid	36384	34574	24684	27936	20614	20794	51648	56576	34494	37614	30326	32948
Pyruvaldehyde	11552	9632	10210	11064	10632	9154	7770	7854	9306	9080	9954	10956
Quinaldic acid	852	600	1730	1702	1922	1926	1466	1484	1890	2228	1806	1654
S-Adenosylhomocysteine	5020	5130	5084	5422	4538	5052	3452	3358	3104	3840	4192	3440
Saccharopine	6068	5022	8596	5414	4450	3254	3880	3004	8098	7112	9610	9802
Salicin	7530	7280	7458	6924	6610	7290	2248	1912	6284	1742	5468	4286
Sebacic acid	34042	28706	35150	41002	31508	30664	19612	24716	36758	33300	39314	38276
Spermine	42508	44976	46800	45118	41352	43814	40898	46682	42638	41696	40994	41436
Sphinganine	15082	15686	14536	13746	13150	9282	4650	4882	2920	2496	3836	3154
Sphingosine	11128	11422	11436	11198	13060	11472	8472	8234	5922	5126	7252	6254
Succinylacetone	18272	17694	9496	17250	17952	16470	11660	13046	7994	9126	16048	15328
Terephthalic acid	5604	4500	5690	5274	3096	2422	1732	2386	4974	3368	5580	1956
Trimethylamine	5110	4944	5088	3504	4444	4230	4292	5128	5216	4592	5866	5610
Uracil	6152	6462	6628	6874	7412	6954	5950	6392	5946	6928	6328	4900
Urea	3684	2966	2682	3084	2266	2668	3074	2148	2300	2570	2520	2424
Uric acid	19608	21062	23310	23642	23974	26662	26702	28906	30828	29178	28750	30910
Uridine	12028	10122	7492	9124	9802	9498	6568	6938	3350	2912	7088	4808
Xanthine	2252	2306	2998	2626	3654	3018	1522	1346	2578	1780	2064	1926
Xanthosine	8336	6464	6430	6428	8276	7240	3764	3770	4274	4942	3326	3122
MS_METABOLITE_DATA_END
#METABOLITES
METABOLITES_START
metabolite_name	Molecular Formula	RT [min]	m/z meas.	M meas.	Ions	MS/MS
1-Methyladenosine	C11H15N5O4	2.21	282.11974	281.11247	[M+H]+	TRUE
17-Hydroxyprogesterone	C21H30O3	19.45	331.22475	330.21748	[M+H]+	TRUE
2'-Deoxyguanosine 5'-monophosphate	C10H14N5O7P	5.35	348.0704	347.06312	[M+H]+	TRUE
2,4-Diaminobutyric acid	C4H10N2O2	13.6	119.08565	118.07837	[M+H]+	TRUE
2-Ethyl-2-hydroxybutyric acid	C6H12O3	6.18	133.08591	132.07863	[M+H]+	TRUE
2-Hydroxyadenine	C5H5N5O	4.75	152.05672	151.04945	[M+H]+	TRUE
2-Phenylaminoadenosine	C16H18N6O4	10.96	381.13087	358.14169	[M+Na]+, [M+H]+, [M+K]+	TRUE
2-Phenylbutyric acid	C10H12O2	15.6	165.09109	164.08382	[M+H]+	TRUE
2-Pyrrolidinone	C4H7NO	6.76	86.06022	85.05295	[M+H]+	TRUE
3,4-Dihydroxyphenylglycol	C8H10O4	2.41	171.06284	170.05556	[M+H]+	TRUE
3-Hydroxy-4-methoxycinnamic aicd	C10H10O4	5.52	195.06285	194.05557	[M+H]+	TRUE
3-Methylindole	C9H9N	5.97	132.08073	131.07346	[M+H]+	TRUE
3a,6b,7b-Trihydroxy-5b-cholanoic acid	C24H40O5	7.42	409.29251	408.28524	[M+H]+	TRUE
5'-Methylthioadenosine	C11H15N5O3S	5.81	298.09682	297.08954	[M+H]+	TRUE
5-Aminopentanoic acid	C5H11NO2	1.6	118.08619	117.07892	[M+H]+	TRUE
5-Methoxysalicylic acid	C8H8O4	10.23	169.04308	168.0358	[M+H]+	TRUE
5-Methoxytryptophol	C11H13NO2	9.67	192.1022	191.09493	[M+H]+	TRUE
7,8-Dihydrobiopterin	C9H13N5O3	1.65	240.10921	239.10194	[M+H]+	TRUE
Acetoin	C4H8O2	8.01	89.05973	88.05246	[M+H]+	TRUE
Adenine	C5H5N5	4.6	136.06172	135.05444	[M+H]+	TRUE
Adenosine	C10H13N5O4	4.6	268.10398	267.09671	[M+H]+	TRUE
Adenosine 3',5'-diphosphate	C10H15N5O10P2	2.18	428.03673	427.02946	[M+H]+	TRUE
Adenosine monophosphate	C10H14N5O7P	2.13	348.07039	347.06311	[M+H]+	TRUE
Adenosine triphosphate	C10H16N5O13P3	2.11	508.00305	506.99577	[M+H]+	TRUE
Allocholic acid	C24H40O5	13.38	409.2952	408.28792	[M+H]+	TRUE
Androstenedione	C19H26O2	9.16	287.19684	286.18993	[M+H]+, [M+K]+	TRUE
Aspartame	C14H18N2O5	5.27	295.1276	294.12033	[M+H]+	TRUE
Aspirin	C9H8O4	4.16	181.0472	180.03992	[M+H]+	TRUE
Atenolol	C14H22N2O3	2.12	267.17036	266.16308	[M+H]+	TRUE
Benzoic acid	C7H6O2	3.26	123.04403	122.03675	[M+H]+	TRUE
Carnosine	C9H14N4O3	1.69	249.09452	226.10532	[M+Na]+, [M+K]+	TRUE
Cinnamaldehyde	C9H8O	13.27	133.06484	132.05757	[M+H]+, [M-H2O+H]+	TRUE
Clotrimazole	C22H17ClN2	1.62	345.10913	344.10185	[M+H]+	TRUE
Coumarin	C9H6O2	3.27	147.04411	146.03683	[M+H]+	TRUE
Cyclic AMP	C10H12N5O6P	2.16	330.06004	329.05276	[M+H]+	TRUE
Cytosine	C4H5N3O	3.59	112.05042	111.04315	[M+H]+	TRUE
D-Glucurono-6,3-lactone	C6H8O6	3.78	177.03289	176.02561	[M+H]+	TRUE
Diacetyl	C4H6O2	8.59	87.04422	86.03694	[M+H]+	TRUE
Diethanolamine	C4H11NO2	10.23	106.08627	105.079	[M+H]+	TRUE
Dopamine	C8H11NO2	5.55	154.08632	153.07904	[M+H]+	TRUE
Elaidic acid	C18H34O2	17.94	283.26337	282.2561	[M+H]+, [M-H2O+H]+	TRUE
Epinephrine	C9H13NO3	5.51	184.09804	183.09076	[M+H]+	TRUE
Folic acid	C19H19N7O6	6.15	442.14723	441.13996	[M+H]+	TRUE
Galactitol	C6H14O6	1.93	183.08636	182.07908	[M+H]+	TRUE
Gamma-Caprolactone	C6H10O2	7.71	58.04142	114.06829	[M+H+H]2+	TRUE
Gluconolactone	C6H10O6	2.14	179.04849	178.04121	[M+H]+	TRUE
Glucosamine	C6H13NO5	5.46	180.08797	179.0807	[M+H]+	TRUE
Glutathione	C10H17N3O6S	2.15	308.09106	307.08333	[M+H]+, [M+Na]+, [M-H2O+H]+	TRUE
Glycerophosphocholine	C8H20NO6P	1.15	258.11012	257.10284	[M+H]+	TRUE
Guanidinosuccinic acid	C5H9N3O4	10.15	176.07068	175.06345	[M+H]+, [M+Na]+	TRUE
Guanosine	C10H13N5O5	4.75	284.09898	283.0917	[M+H]+	TRUE
Guanosine 5'-diphosphate	C10H15N5O11P2	1.77	444.03172	443.02444	[M+H]+	TRUE
Guanosine monophosphate	C10H14N5O8P	3.78	364.06333	363.05606	[M+H]+	TRUE
Hydroxyisocaproic acid	C6H12O3	14.5	133.08603	132.07876	[M+H]+	TRUE
Hyodeoxycholic acid	C24H40O4	20.16	393.29791	392.29063	[M+H]+	TRUE
Hypoxanthine	C5H4N4O	4.76	137.04572	136.03845	[M+H]+, [M-H2O+H]+	TRUE
Indole	C8H7N	5.97	118.06501	117.05774	[M+H]+	TRUE
Indoleacrylic acid	C11H9NO2	5.97	188.07066	187.06339	[M+H]+, [M-H2O+H]+	TRUE
Inosine	C10H12N4O5	4.76	269.08814	268.0811	[M+H]+, [M+K]+, [M+Na]+	TRUE
Isobutyric acid	C4H8O2	7.93	89.05975	88.05247	[M+H]+	TRUE
Isovalerylcarnitine	C12H23NO4	6.34	246.17005	245.16278	[M+H]+	TRUE
L-Acetylcarnitine	C9H17NO4	1.84	204.12308	203.1158	[M+H]+	TRUE
L-Fucose	C6H12O5	1.24	165.07583	164.06856	[M+H]+	TRUE
L-Glutamic acid	C5H9NO4	5.03	148.06058	147.0533	[M+H]+	TRUE
L-Leucine	C6H13NO2	3.26	132.10191	131.09463	[M+H]+	TRUE
L-Methionine	C5H11NO2S	2	150.05829	149.05101	[M+H]+	TRUE
L-Norleucine	C6H13NO2	9.16	132.10198	131.0947	[M+H]+	TRUE
L-Phenylalanine	C9H11NO2	5.13	166.08634	165.07907	[M+H]+	TRUE
L-Proline	C5H9NO2	1.27	116.07058	115.0633	[M+H]+	TRUE
L-Thyronine	C15H15NO4	3.78	274.10296	273.09568	[M+H]+	TRUE
L-Tryptophan	C11H12N2O2	5.97	205.09726	204.08998	[M+H]+	TRUE
L-Tyrosine	C9H11NO3	4.84	182.08122	181.07394	[M+H]+	TRUE
Leucinic acid	C6H12O3	6.46	133.0859	132.07862	[M+H]+	TRUE
m-Coumaric acid	C9H8O3	3.27	165.0547	164.04742	[M+H]+	TRUE
Maltitol	C12H24O11	1.23	345.13916	344.13188	[M+H]+	TRUE
Mannitol	C6H14O6	1.24	183.08635	182.07907	[M+H]+	TRUE
Methyl propenyl ketone	C5H8O	6.33	85.06502	84.05774	[M+H]+	TRUE
Methylhippuric acid	C10H11NO3	5.54	194.07884	193.07156	[M+H]+	TRUE
Metoprolol	C15H25NO3	11.51	268.18841	267.18114	[M+H]+	TRUE
Mevalonic acid	C6H12O4	4.41	171.06285	148.07356	[M+Na]+, [M+H]+, [M-H2O+H]+	TRUE
N,N-Dimethylformamide	C3H7NO	1.34	74.06019	73.05292	[M+H]+	TRUE
N-Acetyl-L-alanine	C5H9NO3	1.33	132.0655	131.0582	[M+H]+, [M-H2O+H]+	TRUE
N-Acetylglutamic acid	C7H11NO5	2.89	212.05301	189.06381	[M+Na]+, [M+H]+	TRUE
N-Acetylserotonin	C12H14N2O2	6.05	219.1105	218.10322	[M+H]+	TRUE
N-Methyl-D-aspartic acid	C5H9NO4	1.2	148.06055	147.05327	[M+H]+	TRUE
Niacinamide	C6H6N2O	2.23	123.05522	122.04794	[M+H]+	TRUE
Nicotinic acid	C6H5NO2	2.17	124.03923	123.03196	[M+H]+	TRUE
Nutriacholic acid	C24H38O4	20.08	413.26653	390.27739	[M+Na]+, [M+H]+, [M+K]+	TRUE
o-Tyrosine	C9H11NO3	5.34	182.08127	181.074	[M+H]+	TRUE
Pantothenic acid	C9H17NO5	5.51	220.11816	219.11072	[M+H]+, [M+Na]+, [M-H2O+H]+	TRUE
Phenol	C6H6O	3.25	95.04913	94.04186	[M+H]+	TRUE
Phenylacetaldehyde	C8H8O	16.56	121.06496	120.05768	[M+H]+	TRUE
Phosphocreatine	C4H10N3O5P	12.14	212.03759	211.03032	[M+H]+	TRUE
Pregnenolone sulfate	C21H32O5S	13.26	397.20114	396.19386	[M+H]+	TRUE
Propionic acid	C3H6O2	8.83	75.04413	74.03686	[M+H]+, [M-H2O+H]+	TRUE
Propranolol	C16H21NO2	5.25	260.16042	259.15314	[M+H]+	TRUE
Pyridine	C5H5N	2.17	80.04965	79.04237	[M+H]+	TRUE
Pyridoxine	C8H11NO3	2.28	152.07065	169.07391	[M-H2O+H]+, [M+H]+	TRUE
Pyrrolidonecarboxylic acid	C5H7NO3	2.38	130.04984	129.04258	[M+H]+, [M+Na]+	TRUE
Pyruvaldehyde	C3H4O2	7.73	73.02844	72.02117	[M+H]+	TRUE
Quinaldic acid	C10H7NO2	2.28	174.05837	173.05109	[M+H]+	TRUE
S-Adenosylhomocysteine	C14H20N6O5S	4.11	385.12895	384.12167	[M+H]+	TRUE
Saccharopine	C11H20N2O6	11.31	277.14116	276.13388	[M+H]+	TRUE
Salicin	C13H18O7	5.31	287.1064	286.09912	[M+H]+	TRUE
Sebacic acid	C10H18O4	8.57	102.06772	202.12089	[M+H+H]2+	TRUE
Spermine	C10H26N4	0.79	203.22309	202.21581	[M+H]+	TRUE
Sphinganine	C18H39NO2	11.29	302.30547	301.29819	[M+H]+	TRUE
Sphingosine	C18H37NO2	13.13	300.28989	299.28262	[M+H]+	TRUE
Succinylacetone	C7H10O4	18.84	159.06523	158.05796	[M+H]+	TRUE
Terephthalic acid	C8H6O4	20.08	149.02343	166.02672	[M-H2O+H]+, [M+H]+	TRUE
Trimethylamine	C3H9N	1.85	60.08089	59.07361	[M+H]+	TRUE
Uracil	C4H4N2O2	3.4	113.03448	112.02721	[M+H]+	TRUE
Urea	CH4N2O	21.6	61.03974	60.03247	[M+H]+	TRUE
Uric acid	C5H4N4O3	2.5	169.03185	168.02457	[M+H]+	TRUE
Uridine	C9H12N2O6	3.41	245.07684	244.06956	[M+H]+	TRUE
Xanthine	C5H4N4O2	5.01	153.04078	152.03351	[M+H]+	TRUE
Xanthosine	C10H12N4O6	5.01	285.08313	284.07586	[M+H]+	TRUE
METABOLITES_END
#END